Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 6 / Drugs : 10 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 10

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Bezafibrate
   University Hospitals Bristol NHS Foundation Trust
      2019   Phase 2   EUCTR2015-001382-10-GB   United Kingdom
Elamipretide
   Stealth BioTherapeutics Inc.
      2026   Phase 4   NCT07531251   United Kingdom;United States
      2021   -   NCT04689360   -
      2017   Phase 2/Phase 3   NCT03098797   United States
Obtaining DRY blood spots from healthy children aged 8 days - 7 years
   West Kazakhstan Medical University
      2022   -   NCT05910151   Kazakhstan
Obtaining DRY blood spots from healthy children aged 8-18 years
   West Kazakhstan Medical University
      2022   -   NCT05910151   Kazakhstan
Triheptanoin
   Jerry Vockley, MD, PhD
      2009   -   NCT01461304   United States